Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company scores highest on Anchor (87) and lowest on Price (10). Its PosiPenta is 59.81 out of 100, around the middle of similar companies.
Compared with similar companies in the Healthcare sector in Saudi Arabia.
The five pillars
Details
PPrice
| P/E ratio | 30.82 |
| P/B ratio | 9.02 |
EEarnings
| Trailing EPS | ₹174.94 |
| Forward EPS | ₹190.13 |
NNitro
| Price | 5392.60 |
| 52-week high | 7012.91 |
| 52-week low | 5248.29 |
| Fall from 52-week high | 23.1% |
TTorque
| Return on equity (ROE) | 30.08% |
| Debt-to-equity | 1.09 |
AAnchor
| Beta (price swings) | 0.03 |
| Market cap | ₹1,88,741 Cr |
| Insider holding | 70.86% |
| Dividend yield | 2.53% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Dr. Sulaiman Al Habib Medical Services Group Company's PosiPenta score?
Dr. Sulaiman Al Habib Medical Services Group Company's PosiPenta is 59.81 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Dr. Sulaiman Al Habib Medical Services Group Company?
Anchor (stability and dividends), with a score of 87 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Dr. Sulaiman Al Habib Medical Services Group Company?
Price (valuation), with a score of 10 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.